We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

74 hedge funds and large institutions have $813M invested in Gossamer Bio in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

19% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 21

4% more funds holding

Funds holding: 71 → 74 (+3)

1.19% more ownership

Funds ownership: 54.49% → 55.68% (+1.2%)

5% more capital invested

Capital invested by funds: $776M → $813M (+$36.5M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
1.61%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
16
Increased
25
Reduced
21
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.58M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.88M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$4.37M
4
State Street
State Street
Massachusetts
+$3.73M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$3.7M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$5.32M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.49M
3
MWNA
Marshall Wace North America
New York
-$3.43M
4
MIM
Monashee Investment Management
Massachusetts
-$3.25M
5
SB
Samsara BioCapital
California
-$2.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
NA
51
Neuburgh Advisers
California
$390K -$52.2K -2,728 -13%
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
$357K +$308K +16,100 New
VEA
53
Virtus ETF Advisers
New York
$292K +$252K +13,168 New
MCIM
54
Meadow Creek Investment Management
Georgia
$284K -$38K -1,984 -13%
AIG
55
American International Group
New York
$282K +$108K +5,641 +80%
Manulife (Manufacturers Life Insurance)
56
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$276K +$238K +12,449 New
Creative Planning
57
Creative Planning
Kansas
$266K – – –
CS
58
Credit Suisse
Switzerland
$256K +$221K +11,547 New
California Public Employees Retirement System
59
California Public Employees Retirement System
California
$225K +$194K +10,158 New
MIM
60
MetLife Investment Management
New Jersey
$221K +$191K +9,986 New
RCM
61
Riverhead Capital Management
Delaware
$209K +$1.28K +67 +0.7%
Royal Bank of Canada
62
Royal Bank of Canada
Ontario, Canada
$154K +$37.6K +1,967 +39%
Citigroup
63
Citigroup
New York
$140K +$61.6K +3,218 +105%
JP Morgan Chase
64
JP Morgan Chase
New York
$126K +$53.5K +2,798 +88%
Legal & General Group
65
Legal & General Group
United Kingdom
$96K +$49.3K +2,577 +148%
Canada Life
66
Canada Life
Manitoba, Canada
$76K +$65.5K +3,421 New
SO
67
STRS Ohio
Ohio
$66K – – –
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
$63K +$32.1K +1,679 +145%
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
$41.5K +$35.8K +1,872 New
AIP
70
Ameritas Investment Partners
Nebraska
$38K +$15.6K +813 +89%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$35K +$30.2K +1,576 New
Morgan Stanley
72
Morgan Stanley
New York
$24K -$19.2K -1,005 -48%
AG
73
Advisor Group
Arizona
$7K +$5.74K +300 New
HDIM
74
Hanson & Doremus Investment Management
Vermont
$3K – – –
MIM
75
Monashee Investment Management
Massachusetts
– -$3.25M -150,000 Closed
1 2
3
4

GOSS Hedge Fund Activity: Q2 2019 in Review

74 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q2 2019, worth a combined $813M — up 4.7% from $776M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new GOSS positions and 11 closed out — a net gain of 5 holders — while 25 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $9.58M. The largest seller was Farallon Capital Management, cutting an estimated $5.32M.

  • 74 institutional investors held Gossamer Bio (GOSS) as of Q2 2019, up from 71 in Q1 2019.
  • Funds reported $813M of Gossamer Bio stock for Q2 2019, up 4.7% quarter-over-quarter.
  • 16 funds opened new Gossamer Bio positions in Q2 2019 and 11 closed out, a net change of +5 holders.
  • The largest Gossamer Bio buyer in Q2 2019 was BlackRock, an estimated $9.58M added.
  • The largest Gossamer Bio seller in Q2 2019 was Farallon Capital Management, an estimated $5.32M sold.

Based on aggregated 13F filings for Q2 2019.